| abstract |
(57) Summary The present invention relates to compounds of formula (I) wherein A 1 , A 2 , R 2 and R 3 have the meanings recited in the claims. The compounds are valuable pharmaceutically active compounds for the treatment and prevention of diseases such as cardiovascular diseases such as hypertension, angina, heart failure, thrombosis, or atherosclerosis. . The compounds of formula (I) are capable of regulating the body production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the treatment and prevention of conditions associated with cGMP metabolic disorders. The present invention also relates to the use of a compound of formula (I), a pharmaceutical formulation containing the compound, and a method of manufacture for the treatment and prevention of the above conditions and for the manufacture of a corresponding medicament. Embedded image |